首页> 外国专利> Combination Therapy of Donepezil and sildenafil for the Treatment of Alzheimer's Disease or Cognitive Impairment

Combination Therapy of Donepezil and sildenafil for the Treatment of Alzheimer's Disease or Cognitive Impairment

机译:多奈哌齐和西地那非联合治疗阿尔茨海默病或认知障碍

摘要

The present invention relates to donepezil and sildenafil combination therapy for the prevention, treatment or amelioration of Alzheimer's disease or cognitive dysfunction. Since the combined administration of donepezil and sildenafil according to the present invention has a superior effect on improving Alzheimer's disease or cognitive dysfunction compared to donepezil alone, it can be usefully used as a treatment regimen for Alzheimer's disease or cognitive dysfunction or as a combination agent.
机译:本发明涉及用于预防、治疗或改善阿尔茨海默病或认知功能障碍的多奈哌齐和西地那非联合疗法。由于与单用多奈哌齐相比,根据本发明的多奈哌齐和西地那非的联合给药在改善阿尔茨海默病或认知功能障碍方面具有更好的效果,因此它可以有效地用作阿尔茨海默病或认知功能障碍的治疗方案或作为联合剂。

著录项

  • 公开/公告号KR20220061046A

    专利类型

  • 公开/公告日2022-05-12

    原文格式PDF

  • 申请/专利权人 주식회사 뉴로라이브;

    申请/专利号KR20210151766

  • 发明设计人 이석찬;지용하;류현희;정미소;

    申请日2021-11-05

  • 分类号A61K31/445;A23L33/10;A61K31/27;A61K31/473;A61K31/4985;A61K31/506;A61K31/519;A61K31/53;A61K31/55;A61P25/28;

  • 国家 KR

  • 入库时间 2022-08-25 00:58:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号